Oxiracetam
Records for this ingredient, by country (identity only).
ATC N06BX · 1 markets · 56 records
CN 56 records · 7 shown of 7
- 1,000 mg/5 mLinjection倍清星奥拉西坦欧兰同、Manufacturer: 华北制药股份有限公司、Manufacturer: 天方药业有限公司、Manufacturer: 安徽新世纪药业有限公司、Manufacturer: 朗天药业(湖北)有限公司、Manufacturer: 河北仁合益康药业有限公司、Manufacturer: 海南通用康力制药有限公司、Manufacturer: 湖南华纳大药厂股份有限公司 +5
- 4,000 mg/20 mLinjection欧兰同奥拉西坦Manufacturer: 朗天药业(湖北)有限公司、Manufacturer: 石家庄凯达生物工程有限公司
- 400 mgcapsule健朗星奥拉西坦欧来宁
- 1,000 mg per mL / per unit basis not statedinjectionManufacturer: 湖南健朗药业有限责任公司 ×2Manufacturer: 石药集团欧意药业有限公司
- 800 mgtabletManufacturer: 河北创健药业有限公司 ×3
- 6,000 mg/20 mLinjectionManufacturer: 石家庄凯达生物工程有限公司 ×6
- 250 mL per mL / per unit basis not statedinjectionManufacturer: 哈尔滨三联药业股份有限公司 ×4
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.